Malaria
remains a global health threatover 400,000 deaths
occurred in 2019. Plasmepsins are promising targets of antimalarial
therapeutics; however, no inhibitors have reached the clinic. To fuel
the progress, a detailed understanding of the pH- and ligand-dependent
conformational dynamics of plasmepsins is needed. Here we present
the continuous constant pH molecular dynamics study of the prototypical
plasmepsin II and its complexed form with a substrate analogue. The
simulations revealed that the catalytic dyads D34 and D214 are highly
coupled in the apo protein and that the pepstatin binding enhances
the difference in proton affinity, making D34 the general base and
D214 the general acid. The simulations showed that the flap adopts
an open state regardless of pH; however, upon pepstatin binding the
flap can close or open depending on the protonation state of D214.
These and other data are discussed and compared with the off-targets
human cathepsin D and renin. This study lays the groundwork for a
systematic investigation of pH- and ligand-modulated dynamics of the
entire family of plasmepsins to help design more potent and selective
inhibitors